We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.62%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$720M
AUM Growth
-$59.6M
(-7.6%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
17.21%
Holding
510
New
74
Increased
122
Reduced
203
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$4.08M |
| 2 |
JBTM
JBT Marel
JBTM
|
+$3.91M |
| 3 |
PRSU
Pursuit Attractions and Hospitality Inc
PRSU
|
+$3.66M |
| 4 |
Northern Oil and Gas
NOG
|
+$3.45M |
| 5 |
Devon Energy
DVN
|
+$3.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DEN
Denbury Inc.
DEN
|
+$7.07M |
| 2 |
Reliance Steel & Aluminium
RS
|
+$5.93M |
| 3 |
CHX
ChampionX
CHX
|
+$4.74M |
| 4 |
Accenture
ACN
|
+$4.11M |
| 5 |
On Holding
ONON
|
+$3.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Consumer Discretionary | 17.64% |
| 3 | Industrials | 15.79% |
| 4 | Healthcare | 11.67% |
| 5 | Financials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEN
26
DELISTED
Denbury Inc.
DEN
| $5.75M | 0.8% |
58,656
-78,061
| -57% | -$7.07M |
|
27
Ferguson
FERG
$44.7B
| $5.43M | 0.75% |
33,038
-12,856
| -28% | -$2.03M |
|
28
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
| $5.25M | 0.73% |
47,548
-4,530
| -9% | -$499K |
|
29
Donnelley Financial Solutions
DFIN
$1.21B
| $4.93M | 0.68% |
87,558
-6,632
| -7% | -$322K |
|
30
Open Text
OTEX
$5.43B
| $4.86M | 0.67% |
138,330
+1,220
| +0.9% | +$47.8K |
|
31
Coca-Cola
KO
$354B
| $4.78M | 0.66% |
85,452
-4,669
| -5% | -$280K |
|
|
IBTD
32
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
| $4.73M | 0.66% |
190,385
-19,500
| -9% | -$483K |
|
33
Symbotic
SYM
$5.11B
| $4.59M | 0.64% |
137,360
-2,853
| -2% | -$117K |
|
|
34
GSK
GSK
$103B
| $4.56M | 0.63% |
125,841
+115,026
| +1,064% | +$4.08M |
|
35
Equinor
EQNR
$95.9B
| $4.54M | 0.63% |
138,583
-5,156
| -4% | -$160K |
|
36
Aehr Test Systems
AEHR
$2.48B
| $4.51M | 0.63% |
98,608
+19,536
| +25% | +$906K |
|
37
HealthEquity
HQY
$7.91B
| $4.5M | 0.62% |
61,609
+35,644
| +137% | +$2.41M |
|
38
RxSight
RXST
$215M
| $4.36M | 0.6% |
156,189
+57,309
| +58% | +$1.71M |
|
39
ATI
ATI
$27B
| $4.25M | 0.59% |
103,382
+19,757
| +24% | +$878K |
|
40
Huron Consulting
HURN
$1.82B
| $4.13M | 0.57% |
39,641
-7,712
| -16% | -$734K |
|
41
Vanguard Ultra-Short Bond ETF
VUSB
$8.93B
| $4.11M | 0.57% |
83,475
+16,275
| +24% | +$799K |
|
42
Duolingo
DUOL
$5.7B
| $3.92M | 0.54% |
23,637
+12,321
| +109% | +$1.81M |
|
43
Sweetgreen
SG
$713M
| $3.91M | 0.54% |
332,621
+88,155
| +36% | +$1.23M |
|
44
Fluor
FLR
$7.29B
| $3.72M | 0.52% |
101,435
+91,162
| +887% | +$3.05M |
|
45
Alphabet (Google) Class A
GOOGL
$3.91T
| $3.71M | 0.52% |
28,372
-4,368
| -13% | -$565K |
|
|
JBTM
46
JBT Marel
JBTM
$7.14B
| $3.67M | 0.51% |
+34,900
| New | +$3.91M |
|
47
Amazon
AMZN
$2.5T
| $3.57M | 0.5% |
28,108
-1,549
| -5% | -$208K |
|
48
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $3.55M | 0.49% |
204,098
+173,546
| +568% | +$2.92M |
|
|
49
Northern Oil and Gas
NOG
$2.3B
| $3.52M | 0.49% |
+87,503
| New | +$3.45M |
|
50
First Advantage
FA
$3.37B
| $3.33M | 0.46% |
241,296
-4,515
| -2% | -$65.6K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q3 2023 Portfolio in Review
As of Q3 2023, Advisory Research held 510 positions worth $720M, down 7.6% from $780M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Advisory Research withdrew a net $36.5M in Q3 2023, closing 86 positions and reducing 203 holdings. Its most notable exit was Livent Corporation, an estimated $2.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Advisory Research opened a new position in JBT Marel worth $3.67M.
- Advisory Research's largest Q3 2023 buy was JBT Marel: 34,900 shares worth $3.67M.
- Advisory Research added most to GSK in Q3 2023, an estimated $4.08M increase.
- Advisory Research's biggest Q3 2023 reduction was Denbury Inc., cutting an estimated $7.07M.
- Advisory Research fully exited Livent Corporation in Q3 2023, selling an estimated $2.81M.
- Advisory Research's ten largest holdings make up 17% of its $720M portfolio in Q3 2023.
- Advisory Research opened 74 new positions and closed 86 in Q3 2023.
- Advisory Research's portfolio value fell 7.6% quarter-over-quarter to $720M.
Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.